- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
7
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
7 companies
PharmaEngine
Market Cap: NT$10.5b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$70.60
7D
-1.8%
1Y
-26.8%
Syngen BiotechLtd
Market Cap: NT$3.4b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$127.00
7D
-0.8%
1Y
-3.1%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.1b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$62.70
7D
5.4%
1Y
-1.4%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.4b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$76.60
7D
-1.8%
1Y
-20.8%
YungShin Global Holding
Market Cap: NT$14.6b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$54.80
7D
-0.4%
1Y
-5.2%
TTY Biopharm
Market Cap: NT$19.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$78.40
7D
-1.0%
1Y
7.4%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.7b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.40
7D
-2.7%
1Y
2.3%